The present invention relates to novel quinolinone derivatives (I), efficacious in animal models of CNS disorders and, as such, valuable candidates for the prevention or treatment of CNS (Central Nervous System) diseases or disorders. In other aspects the invention relates to pharmaceutical compositions comprising the quinolinone derivatives of the invention and to the use of these compounds for therapeutic applications.
本发明涉及新型
喹诺酮衍
生物(I),在动物中枢神经系统疾病模型中表现出高效,并因此是预防或治疗中枢神经系统疾病或疾病的有价值候选药物。在其他方面,本发明涉及包含本发明的
喹诺酮衍
生物的药物组合物,以及利用这些化合物进行治疗应用。